Wealth Enhancement Advisory Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$725K	Buy	+21,622	New	+$648K	﹤0.01%	2339

Other funds holding IDNA

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HWA

HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return

Wealth Enhancement Advisory Services's IDNA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 21,622 shares worth $725K. The stake represents ﹤0.01% of the portfolio and ranks #2339 among its holdings.

6 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Wealth Enhancement Advisory Services held 21,622 shares of iShares Genomics Immunology and Healthcare ETF worth $725K as of Q2 2026.
iShares Genomics Immunology and Healthcare ETF was a new Wealth Enhancement Advisory Services position in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2339 holding.
6 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.